HEXO provides update on Redecan acquisition
July 14 2021 - 6:31AM
HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) is
pleased to announce, that in connection with its previously
announced acquisition of the entities operating the business of
Redecan, it has now obtained and will be shortly filing the
recently completed audited consolidated financial statements of
Redecan for the financial year ended December 31, 2020 (“FY20”) and
the unaudited interim financial statements for the first quarter
ended March 31, 2021 (“1Q21”) prepared in accordance with
Accounting standards for private enterprises (“ASPE”). The Company
previously announced a definitive share purchase agreement to
acquire Redecan, Canada’s largest privately-owned licensed
producer.
“Redecan has the top consumer loyalty in Canada, impressive
market share and leading products in key categories. Today, we are
excited to finally share additional financial information with HEXO
shareholders,” said HEXO CEO and co-founder Sebastien St-Louis.
“Redecan’s historical financial statements demonstrate exactly what
we already knew: Redecan is one of the fastest growth LPs in Canada
with positive income from operations, impressive margins, lean
operational efficiency and strong revenue. Once closed, the
acquisition will further strengthen our position as a leader in the
Canadian cannabis industry, bolster the Company as we look towards
becoming a top three global cannabis products company and put us
firmly on the path towards positive EPS.”
Key Financial Highlights (as per ASPE unless otherwise
stated):
- Revenue, net of excise duties of $73.6M for F20 and $24.7
million in Q1 F21, representing an increase of 146% over Q1
F20
- Unadjusted EBITDA of $28.9M for F20 and $12.4M for Q1 F21, per
the following reconciliation:
|
Q1 F21 |
F20 |
Net Earnings |
6,913,624 |
11,624,161 |
Add back: |
|
|
Amortization |
4,216,528 |
12,174,795 |
Impairment loss on property, plant and equipment |
37,235 |
588,593 |
Provision for income taxes |
1,230,000 |
4,499,595 |
Unadjusted EBITDA |
12,397,387 |
28,887,144 |
- Income from operations of $8.3M and net earnings of $6.9M in Q1
F21.
- Income from operations of $16.7M and net earnings of $11.6
million in F20.
- Gross margins (gross margin divided by revenue, net of excise
duties) of 51% in F20 and 58% in Q1 F21.
- Selling, general and administrative costs, (defined as General
and administrative, plus marketing and promotion, plus research and
development) as a % of sales of 27% in F20 and 23% in Q1 F21.
- Depreciable capital base, consisting of property, plant and
equipment, was $84.1M at December 31, 2020, the lowest of any of
the top 6 licensed producers in Canada.
Proforma Highlights for the Nine Months ended April 30, 2021 for
HEXO Corp and the Nine Months ended March 31, 2021 for Redecan,
adjusted to International Financial Reporting Standards
(IFRS)*:
- Net revenue of $155.6M.
- Gross margin before fair value adjustments of $69.1M, or
44.4%.
- Income from operations of $38.6M.
The Redecan acquisition is expected to close in calendar Q3
2021, subject to the satisfaction of customary closing conditions,
including the receipt of applicable regulatory approvals and the
shareholder approval described above required under TSX rules.
Redecan’s historical financial statements for the financial year
ended December 31, 2020 and for the first quarter ended March 31,
2021 as well as certain pro forma financial statements giving
effect to the acquisition of Redecan by HEXO have been filed or
furnished, as applicable, as schedules to an amended and restated
material change report dated July 14, 2021 available under the
Company’s profile on SEDAR at www.sedar.com and EDGAR at
www.sec.gov respectively.
About HEXO
HEXO is an award-winning licensed producer of innovative
products for the global cannabis market. HEXO serves the Canadian
recreational market with a brand portfolio including HEXO, UP
Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and
the medical market in Canada, Israel and Malta. The Company also
serves the Colorado market through its Powered by HEXO® strategy
and Truss CBD USA, a joint-venture with Molson Coors. In the event
that the previously announced transactions to acquire 48North and
Redecan close, HEXO expects to be the number one cannabis products
company in Canada by recreational market share.
For more information, please visit www.hexocorp.com.
*The Company’s unaudited pro forma condensed consolidated
statement of financial position as of April 30, 2021 and the
unaudited pro forma condensed consolidated statements of net
earnings (loss) for the nine months ended April 30, 2021 and the
year ended July 31, 2020 have been prepared by management of HEXO
for the purpose of presenting the impact of the Acquisition, as
described therein. Although the Acquisition had not closed as
of the date of the pro forma financial statements, the unaudited
pro forma condensed consolidated statement of financial position
includes the effect of the Acquisition as if it had occurred on
April 30, 2021. The unaudited pro forma condensed
consolidated statement of net earnings (loss) for the nine months
ended April 30, 2021 and the year ended July 31, 2020 give effect
to the Acquisition as if it had occurred on August 1, 2019.
The unaudited pro forma condensed consolidated financial
statements, including the notes thereto, should be read in
conjunction with HEXO’s historical financial statements, and
respective Management’s Discussion and Analysis of financial
condition and results of operations as filed with or furnished to,
as applicable, the Canadian and U.S. securities regulatory
authorities and Redecan’s historical financial statements. The
unaudited pro forma condensed consolidated financial statements are
based on assumptions and adjustments that are described in the
notes to such pro forma financial statements The unaudited pro
forma condensed consolidated financial statements do not give
effect to the potential impact of current financial conditions,
regulatory matters, operating efficiencies or other savings or
expenses that may be associated with the integration of the
Acquisition. The unaudited pro forma condensed consolidated
financial statements have been prepared for illustrative purposes
only and are not necessarily indicative of the financial position
or results of operations in future periods or the results that
actually would have been realized if HEXO and the acquired company
(being the Redecan Group) had been a consolidated company during
the specified periods. The application of the acquisition method of
accounting depends on certain valuations and other studies that
have yet to be completed. Accordingly, the pro forma adjustments
are preliminary, subject to further revisions as additional
information becomes available and additional analyses are performed
and have been made solely for the purposes of providing unaudited
pro forma condensed consolidated financial statements. Differences
between these preliminary estimates and the final acquisition
accounting will occur and these differences could have a material
impact on the accompanying unaudited pro forma condensed
consolidated financial statements and the consolidated company’s
future earnings and financial position. Further, differences
between the preliminary and final amounts will likely occur as a
result of changes in the fair value of HEXO’s common shares to
determine the actual purchase consideration for the Acquisition, as
well as the actual amount of cash used in Redecan’s operations, and
other changes in assets and liabilities.
Non-IFRS/Non-ASPE Measures
In this press release, reference is made to unadjusted EBITDA,
which is not a measure of financial performance under International
Financial Reporting Standards (IFRS) or Accounting Standards for
Private Enterprises (ASPE). This metric and measure is not a
recognized measure under IFRS or ASPE, does not have meanings
prescribed under IFRS or ASPE and is as a result unlikely to be
comparable to similar measures presented by other companies. This
measure is provided as information complementary to those IFRS and
ASPE measures by providing a further understanding of HEXO and
Redecan’s operating results from the perspective of
management. As such, this measure should not be considered in
isolation or in lieu of a review of HEXO and Redecan’s financial
information reported under IFRS or ASPE respectively.
Forward Looking Statements
This press release contains forward-looking information and
forward-looking statements within the meaning of applicable
securities laws (“forward-looking statements”). Forward-looking
statements are based on certain expectations and assumptions and
are subject to known and unknown risks and uncertainties and other
factors that could cause actual events, results, performance and
achievements to differ materially from those anticipated in these
forward-looking statements. Forward-looking statements should not
be read as guarantees of future performance or results. Readers are
cautioned not to place undue reliance on these forward-looking
statements, which speak only as of the date of this press release.
The Company disclaims any intention or obligation, except to the
extent required by law, to update or revise any forward-looking
statements as a result of new information or future events, or for
any other reason.
Investor
Relations:invest@HEXO.comwww.hexocorp.com
Media Relations:(819)
317-0526media@hexo.com
HEXO (TSX:HEXO)
Historical Stock Chart
From Dec 2024 to Jan 2025
HEXO (TSX:HEXO)
Historical Stock Chart
From Jan 2024 to Jan 2025